Description
Elvitegravirisanantiviralcompoundthatinhibitsintegraseactivity.ThiscompoundisclinicallyusedtotreatHIVinfection.
Elvitegravirisanantiviralcompoundthatinhibitsintegraseactivity.ThiscompoundisclinicallyusedtotreatHIVinfection.
| CasNo. | 697761-98-1 |
|---|---|
| Purity | ≥98% |
| Formula | C23H23ClFNO5 |
| FormulaWt. | 447.88 |
| IUPACName | 6-[(3-chloro-2-fluorophenyl)methyl]-1-[(2S)-1-hydroxy-3-methylbutan-2-yl]-7-methoxy-4-oxoquinoline-3-carboxylicacid |
| Appearance | Whitetooffwhitepowder |
| StoreTemp | Ambient |
|---|---|
| ShipTemp | Ambient |
| InfoSheet | E4785InfoSheetPDF |
|---|---|
| Brochures | AntiviralsBooklet |
ReviriegoC.ElvitegravirforthetreatmentofHIVinfection.DrugsToday(Barc).2014Mar;50(3):209-17.PMID:24696866.
ShimuraK,KodamaE,SakagamiY,etal.Broadantiretroviralactivityandresistanceprofileofthenovelhumanimmunodeficiencyvirusintegraseinhibitorelvitegravir(JTK-303/GS-9137).JVirol.2008Jan;82(2):764-74.PMID:17977962.